EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bausch Health's enterprise value is $24,561 Mil.
Bausch Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $2,202 Mil. Therefore, Bausch Health's EV-to-EBITDA for today is 11.15.
The historical rank and industry rank for Bausch Health's EV-to-EBITDA or its related term are showing as below:
BHC'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 7.85 Med: 16.45 Max: 191.49
Current: 11.34
During the past 13 years, the highest EV-to-EBITDA of Bausch Health was 191.49. The lowest was 7.85. And the median was 16.45.
BHC's EV-to-EBITDA is ranked better than 59.32% of 708
companies
in the Drug Manufacturers industry
Industry Median: 14.075
vs BHC: 11.34
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Bausch Health's stock price is $8.56.
Bausch Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-1.620. Therefore, Bausch Health's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Bausch Health EV-to-EBITDA Historical Data
The historical data trend for Bausch Health's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bausch Health's EV-to-EBITDA
For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch Health's EV-to-EBITDA Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Bausch Health's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Bausch Health's EV-to-EBITDA falls into.
Bausch Health EV-to-EBITDA Calculation
Bausch Health's EV-to-EBITDA for today is calculated as:
Bausch Health's current Enterprise Value is $24,561 Mil.
Bausch Health's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2,202 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bausch Health (NYSE:BHC) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Bausch Health's PE Ratio for today is calculated as:
Bausch Health's share price for today is $8.56.
Bausch Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.620.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Bausch Health's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Bausch Health (Bausch Health) Business Description
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BHC has been successfully added to your 